Category: Biotechnology
Global Biotechnology
-
Chiral Chemicals
... CAGR of 6.3% over the analysis period 2023-2030. Traditional Separation Method, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$50.8 Billion by the end of the ... Read More
-
Custom Antibody
... CAGR of 9.0% over the analysis period 2023-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$320.3 Million by the end of the analysis ... Read More
-
IR Spectroscopy
... CAGR of 5.0% over the analysis period 2023-2030. Benchtop IR Spectroscopy, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$647.6 Million by the end of the ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
Disposable Respirators
... CAGR of 4.5% over the analysis period 2023-2030. N-Series Respirators, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Chromatographic Silica Resins
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Process Chromatography Application, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$63.8 Million ... Read More
-
Genotyping
... of 15.4% over the analysis period 2023-2030. Genotyping Reagents & Kits, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$28.1 Billion by the end of the ... Read More
-
Grain Analysis
... at a CAGR of 4.8% over the analysis period 2023-2030. Cereals Grain Analysis, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.2 Billion by the end ... Read More
-
Human Identification
... at a CAGR of 7.8% over the analysis period 2023-2030. Human Identification Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.0 Billion by ... Read More
-
GMO Testing
... at a CAGR of 6.9% over the analysis period 2023-2030. Stacked Trait Testing, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.6 Billion by the end ... Read More
-
Optical Emission Spectroscopy (OES)
... reach US$1.2 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. OES Equipment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach ... Read More
-
Spine Biologics
... at a CAGR of 4.4% over the analysis period 2023-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Stem Cell Assays
... by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by ... Read More
-
Albumin
... of 3.7% over the analysis period 2023-2030. Human Serum Albumin, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$902.4 Million by the end of the analysis ... Read More
-
Orthobiologics
... of 4.1% over the analysis period 2023-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Glycomics / Glycobiology
... by 2030, growing at a CAGR of 16.9% over the analysis period 2023-2030. Enzymes, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.9 Billion by the ... Read More
-
Up-Regulated Protein
... at a CAGR of 6.1% over the analysis period 2023-2030. Diagnostic Labs End-Use, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$300.9 Million by the end ... Read More
-
Beta Interferon
... at a CAGR of 3.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$943.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is ... Read More
-
Live Cell Encapsulation
... at a CAGR of 3.7% over the analysis period 2023-2030. Alginate Polymer, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of ... Read More
-
Global Viral Vectors Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Viral Vectors Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Bone Cement Injector Kit Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Bone cement injector kits are use in bone cement procedures. The ... Read More
-
Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033
... Organizations; Contract Research Organizations; Academic Research InstitutesCovering: Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Sartorius Stedim Biotech; Getinge Group Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033 from The Business ... Read More
-
Global Digestive Remedies Market: Analysis By Type (Antacids, Laxatives, Diarrheal Remedies, Proton Pump Inhibitors (PPIs), Digestive Enzymes, Motion Sickness, and Others), By Formulation (Capsules, Tablets, Powder, and Others), By Distribution Channel (Pharmacies & Drugstores, Online Providers, and Others), By End User (Adults, and Pediatrics), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... Providers, and Others), By End User (Adults, and Pediatrics), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2029 Base Year 2023 ... Read More
-
Lyophilization Services For Biopharmaceuticals Global Market Opportunities And Strategies To 2033
... Cartridges3) By Application: Pharmaceutical And Biotechnology Companies; Research InstitutesCovering: PCI Pharma Services; OFD LLC (Oregon Freeze Dry); Simtra BioPharma Solutions (Baxter); Vetter Pharma-Fertigung GmbH & Co. KG; IDT Biologika GmbH Lyophilization Services For Biopharmaceuticals Global ... Read More
-
Global Non-viral Vectors Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Non-viral Vectors Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
Research Assistance
